CopilotIQ / Biofourmis
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CopilotIQ / Biofourmis - overview
Location
-, -, US
Primary Industry
Healthcare IT
About
Based in the US, and established in 2024, CopilotIQ and Biofourmis are combined and formed new entity CopilotIQ / Biofourmis. CopilotIQ, the health tech company helping older Americans with chronic conditions live longer and healthier lives, and Biofourmis, a global technology-enabled care delivery company, delivering in-home care solutions serving enterprise healthcare customers. The combined company was creatd as an AI-driven platform that delivers in-home care across the full spectrum from pre-surgical optimization to acute, post-acute, and chronic care. In addition, as part of this combination, investors from both businesses including General Atlantic, Openspace Ventures, and Bessemer Venture Partners are investing into the combined business.
Primary Industry
Healthcare IT
Sub Industries
Healthcare, Healthcare IT
Verticals
HealthTech
Total Amount Raised
Subscriber access only
CopilotIQ / Biofourmis - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | Biofourmis Inc., CopilotIQ | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.